Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 1.7x - 1.9x | 1.8x |
| Historical Pb Multiple | 0.4x - 2.3x | 0.5x |
| Fair Value | ₹33.81 - ₹37.37 | ₹35.59 |
| Upside | -9.8% - -0.4% | -5.1% |
| Benchmarks | - | Full Ticker |
| JHS Svendgaard Laboratories Limited | 53,277,100.0% | BSE:532771 |
| Cupid Limited | 53,084,300.0% | BSE:530843 |
| Radix Industries (India) Limited | 53,141,200.0% | BSE:531412 |
| Paramount Cosmetics (India) Limited | 50,797,000.0% | BSE:507970 |
| Sandu Pharmaceuticals Limited | 52,470,300.0% | BSE:524703 |
| Novateor Research Laboratories Limited | 54,277,100.0% | BSE:542771 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 532771 | 530843 | 531412 | 507970 | 524703 | 542771 | |||
| BSE:532771 | BSE:530843 | BSE:531412 | BSE:507970 | BSE:524703 | BSE:542771 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | 21.2% | 12.4% | NM- | 16.9% | -33.1% | ||
| 3Y CAGR | NM- | 11.2% | 16.7% | -60.3% | 10.2% | 35.4% | ||
| Latest Twelve Months | -123.9% | 116.8% | 26.8% | -157.9% | 59.5% | 62.3% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -8.7% | 19.9% | 6.4% | 0.3% | 2.0% | -15.4% | ||
| Prior Fiscal Year | -4.4% | 19.8% | 5.8% | 0.8% | 2.3% | 2.9% | ||
| Latest Fiscal Year | -21.2% | 23.3% | 6.8% | 0.1% | 2.2% | 2.4% | ||
| Latest Twelve Months | -28.0% | 27.9% | 5.9% | -0.8% | 2.6% | 3.5% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -4.0% | 22.0% | 9.3% | 0.5% | 3.7% | -0.5% | ||
| Prior Fiscal Year | -2.3% | 20.4% | 8.4% | 1.1% | 4.0% | 0.5% | ||
| Latest Twelve Months | -14.2% | 21.6% | 13.9% | -0.8% | 4.5% | 0.7% | ||
| Next Fiscal Year | -12.5% | 11.1% | 18.9% | 0.1% | 4.2% | #NUM! | ||
| Two Fiscal Years Forward | -14.3% | 10.2% | 20.4% | 0.1% | 4.3% | 0.3% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 1.4x | 8.5x | 5.8x | 1.0x | 0.7x | 11.0x | ||
| Price / LTM EPS | -5.1x | 30.3x | 98.5x | -122.6x | 25.5x | 316.0x | ||
| Price / Book | 0.7x | 5.0x | 12.9x | 0.9x | 1.1x | 1.9x | ||
| Price / Fwd Book | 0.8x | 4.8x | 11.6x | 0.9x | 1.1x | 2.1x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 0.7x | 1.1x | 12.9x | |||||
| Historical P/B Ratio | 0.4x | 0.5x | 2.3x | |||||
| Selected P/B Multiple | 1.7x | 1.8x | 1.9x | |||||
| (x) Book Value | 96 | 96 | 96 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 532771 | 530843 | 531412 | 507970 | 524703 | 542771 | |
| Value of Common Equity | 1,241 | 16,288 | 2,650 | 192 | 464 | 181 | |
| (/) Shares Outstanding | 85.6 | 268.5 | 15.0 | 4.9 | 9.7 | 4.8 | |
| Implied Stock Price | 14.50 | 60.67 | 176.60 | 39.51 | 48.04 | 37.50 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 14.50 | 60.67 | 176.60 | 39.51 | 48.04 | 37.50 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |